Back
  1. Home
  2. Profile of Michel Vanhaeverbeek (UMONS)
Profil

Vanhaeverbeek Michel

Main Referenced Co-authors
Van Antwerpen, P. (7)
Zouaoui boudjeltia, Karim  (7)
DUFRASNE, François  (6)
Nève, Jean (5)
Babar, Sajida (4)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (6)
Cardiovascular & respiratory systems (1)
General & internal medicine (1)
Phytobiology (plant sciences, forestry, mycology...) (1)
Chemistry (1)

Publications (total 7)

The most downloaded
15 downloads
Soubhye, J., Prévost, M., Elfving, B., Gelbcke, M., Podrecca, M., Conotte, R., Colet, J.-M., Furtmuller, P. G., Delporte, C., Rousseau, A., Vanhaeverbeek, M., Nève, J., Obinger, C., Zouaoui Boudjeltia, K., Van Antwerpen, P., & Dufrasne, F. (01 August 2014). Hybrid Molecules Inhibiting Myeloperoxidase Activity and Serotonin Reuptake: A Possible New Approach of Major Depressive Disorders with Inflammatory Syndrome. Journal of Pharmacy and Pharmacology, 66, 1122 - 133. doi:10.1111/jphp.12236 https://hdl.handle.net/20.500.12907/19437

The most cited

38 citations (Scopus®)

Soubhye, J., Aldib, I., Elfving, B., Gelbcke, M., Furtmuller, P. G., Podrecca, M., Conotte, R., Colet, J.-M., Rousseau, A., Reyé, F., Sarakbi, A., Vanhaeverbeek, M., Kauffmann, J.-M., Obinger, C., Nève, J., Prevost, M., Zouaoui Boudjeltia, K., Dufrasne, F., & Van Antwerpen, P. (23 May 2013). Design, Synthesis, and Structure-Activity Relationship Studies of Novel 3-Alkylindole Derivatives as Selective and Highly Potent Myeloperoxidase Inhibitors. Journal of Medicinal Chemistry, 56 (10), 3943-3958. doi:10.1021/jm4001538 https://hdl.handle.net/20.500.12907/28733

Soubhye, J., Prévost, M., Elfving, B., Gelbcke, M., Podrecca, M., Conotte, R., Colet, J.-M., Furtmuller, P. G., Delporte, C., Rousseau, A., Vanhaeverbeek, M., Nève, J., Obinger, C., Zouaoui Boudjeltia, K., Van Antwerpen, P., & Dufrasne, F. (01 August 2014). Hybrid Molecules Inhibiting Myeloperoxidase Activity and Serotonin Reuptake: A Possible New Approach of Major Depressive Disorders with Inflammatory Syndrome. Journal of Pharmacy and Pharmacology, 66, 1122 - 133. doi:10.1111/jphp.12236
Peer Reviewed verified by ORBi

Soubhye, J., Aldib, I., Elfving, B., Gelbcke, M., Furtmuller, P. G., Podrecca, M., Conotte, R., Colet, J.-M., Rousseau, A., Reyé, F., Sarakbi, A., Vanhaeverbeek, M., Kauffmann, J.-M., Obinger, C., Nève, J., Prevost, M., Zouaoui Boudjeltia, K., Dufrasne, F., & Van Antwerpen, P. (23 May 2013). Design, Synthesis, and Structure-Activity Relationship Studies of Novel 3-Alkylindole Derivatives as Selective and Highly Potent Myeloperoxidase Inhibitors. Journal of Medicinal Chemistry, 56 (10), 3943-3958. doi:10.1021/jm4001538
Peer Reviewed verified by ORBi

Chodzynski, K., Conotte, S., Vanhamme, L., Van Antwerpen, P., Kerkhofs, M., Legros, J. L., Vanhaeverbeek, M., Van Meerhaeghe, A., Coussement, G., Zouaoui Boudjeltia, K., & Legrand, A. (02 April 2013). A new device to mimic intermittent hypoxia in mice. PLoS ONE, 8 (4), 1-10.
Peer Reviewed verified by ORBi

Van Antwerpen, P., Zouaoui Boudjeltia, K., Dufrasne, F., Babar, S., Moreau, P., Moguilevsky, N., Prevost, M., Vanhaeverbeek, M., Nève, J., & Ducobu, J. (2008). Tryptamine derivatives inhibit the myeloperoxidase-dependent LDL oxidation. Atherosclerosis. Supplements.
Peer Reviewed verified by ORBi

Van Antwerpen, P., Moreau, P., Zouaoui Boudjeltia, K., Babar, S., Dufrasne, F., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Nève, J. (2007). Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme. Talanta.
Peer Reviewed verified by ORBi

Van Antwerpen, P., Prevost, M., Zouaoui Boudjeltia, K., Babar, S., Lessgyer, I., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Dufrasne, F. (07 November 2007). Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification. Bioorganic and Medicinal Chemistry, 16 (4), 1702-1720.
Peer Reviewed verified by ORBi

Van Antwerpen, P., Dufrasne, F., Lequeux, M., Zouaoui Boudjeltia, K., Lessgyer, I., Babar, S., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Nève, J. (12 June 2007). Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: Flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid. European Journal of Pharmacology, 570 (1-3), 235-243.
Peer Reviewed verified by ORBi

Contact ORBi UMONS